ArticleProceedings of the National Academy of Sciences of the United States of America2026
NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma.
Maria C White et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.